Preventing cerebral palsy: Paths not (yet) taken

Developmental Medicine and Child Neurology

Volumn 51, Issue 10, 2009, Pages 765-766

  Nelson, Karin B ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; OXYGEN; THYROID ANTIBODY; THYROID HORMONE;

CEREBRAL PALSY; CHILD; CLINICAL RESEARCH; DISEASE ASSOCIATION; EDITORIAL; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEVER; GENOTYPE; HUMAN; INDUCED HYPOTHERMIA; MATERNAL WELFARE; MEDICAL RESEARCH; MENSTRUAL IRREGULARITY; NEUROLOGIC DISEASE; NEUROPROTECTION; OVARY POLYCYSTIC DISEASE; OXYGEN SUPPLY; PERINATAL ASPHYXIA; PLACENTA DISORDER; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RISK ASSESSMENT; SOCIAL STATUS; STROKE; THYROID DISEASE;

CEREBRAL PALSY; HUMANS;

EID: 70349561827     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2009.03489.x     Document Type: Editorial

References (17)

1. Hong T, Paneth N. Maternal and infant thyroid disorders and cerebral palsy. Semin Perinatol 2008; 32: 438-45.
2. Adamson SJ, Alessandri LM, Badawi N, Burton PR, Pemberton PJ, Stanley F. Predictors of neonatal encephalopathy in full-term infants. Br Med J 1995; 311: 598-602.
3. Badawi N, Kurinczuk JJ, Keogh JM, et al. Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study. Br Med J 1998; 317: 1549-53.
4. Ellis M, Manandhar N, Manandhar DS, Costello AM. Risk factors for neonatal encephalopathy in Kathmandu, Nepal, a developing country: unmatched case-control study. Br Med J 2000; 320: 1229-36.
5. McElduff A, Morris J. Thyroid function tests and thyroid autoantibodies in an unselected population of women undergoing first trimester screening for aneuploidy. Aust NZ J Obstet Gynaecol 2008; 48: 478-80.
6. Mitchell ML, Hermos RJ, Larson CA. Thyroid peroxidase antibodies in dried blood specimens of newborns. Thyroid 2002; 12: 609-11.
7. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 1986; 315: 81-86.
8. Torfs C, van den Berg B, Oechesli FW, Cummins S. Prenatal and perinatal factors in the etiology of cerebral palsy. J Pediatr 1990; 116: 615-19.
9. Walstab JE, Bell R, Reddihough DS, Brennecke SP, Bessell C, Beischer N. Antenatal and intrapartum antecedents of cerebral palsy: a case-control study. Aust N Z J Obstet Gynaecol 2002; 42: 138-46.
10. Nelson KB. Infection in pregnancy and cerebral palsy. Dev Med Child Neurol 2009; 52: 253-54.
11. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomized trial. Lancet 2005; 365: 663-70.
12. Rouse DJ. Magnesium sulfate for the prevention of cerebral palsy. Am J Obstet Gynecol 2009; 200: 610-12.
13. Bhat MA, Charoo BA, Bhat JI, Ahmad SM, Ali SW, Mufti MH. Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial. Pediatrics 2009; 123: e764-69.
14. Meloni BP, Campbell K, Zhu H, Knuckey NW. In search of clinical neuroprotection after brain ischemia: the case for mild hypothermia (35° C) and magnesium. Stroke 2009; 40: 2236-40.
15. Badawi N, Felix JF, Kurinczuk JJ, et al. Cerebral palsy following term newborn encephalopathy: a population-based study. Dev Med Child Neurol 2005; 47: 293-98.
16. Badawi N, Kurinczuk JJ, Keogh JM, et al. Intrapartum risk factors for newborn encephalopathy: the Western Australia case-control study. Br Med J 1998; 317: 1554-58.
17. Evans K, Rigby AS, Hamilton P, Titchiner N, Hall DM. The relationships between neonatal encephalopathy and cerebral palsy: a cohort study. J Obstet Gynaecol 2001; 21: 114-20.